SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-056320
Filing Date
2019-11-13
Accepted
2019-11-13 16:05:35
Documents
2
Period of Report
2019-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1603
2 POA DOCUMENT poa.txt EX-24.3_879278 3595
  Complete submission text file 0001209191-19-056320.txt   6623
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Issuer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BLVD., SUITE 400 DURHAM NC 27703
Business Address
Hollander David (Reporting) CIK: 0001793796 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36152 | Film No.: 191213953